Reference 12b
Human papillomavirus testing in women with cytological prediction of low-grade abnormality
Human papillomavirus testing in women with cytological prediction of low-grade abnormality
Reference No. | 12b |
| Reference Name | Human papillomavirus testing in women with cytological prediction of low-grade abnormality |
| Advisory Panel | Professor Brendon Kearney (Chair and MSAC member) Professor Sydney Bell (MSAC member) Dr Paul Craft (MSAC member) Dr Ray Kirk (MSAC member) Dr Dwina Dobriansky (Royal Australian and New Zealand College of Obstetricians and Gynaecologists nominee) Dr Annabelle Farnsworth (Department of Health and Ageing - member until 7 August 2002) Dr Alistair Lochhead (Royal College of Pathologists of Australasia nominee) Dr Heather Mitchell (co-opted member) Dr Marion Saville (Australian Society of Cytology nominee) Dr Judy Straton (Department of Health and Ageing) Dr Lynnette Wray (Royal Australian College of Cytology nominee) Ms Kathleen Mazzella (Consumers' Health Forum of Australia nominee) |
| Date Received by MSAC Secretariat | June 2001 |
| Stage 1 - Eligibility | Eligible |
| Stage 2 - Assessment | Completed |
| Stage 3 - Formulation of Advice to the Minister | This assessment was considered by the MSAC at the 21 August 2002 meeting. Since there is currently insufficient evidence pertaining to the use of human papillomavirus NAA test for triaging of women with equivocal cervical screening results, the MSAC recommended that public funding should not be supported at this time for this diagnostic procedure. |
| Stage 4 - Decision | Endorsed by the Minister for Health and Ageing 16 October 2002 |
| Stage 5 - Implementation |  |
Page currency, Latest update: 30 March, 2009
